Skip to content

Clinical trials

Phase 2 Leukemia, Hairy Cell trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Hairy Cell Phase: Phase 2 Country / region: United States Clear all

51 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20021
20032
20043
20054
20065
20072
20083
20092
20104
20111
20123
20133
20142
20181
20201
20211
20223
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed31
Terminated8
Active, not recruiting7
Recruiting3
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center12
National Cancer Institute (NCI)12
Memorial Sloan Kettering Cancer Center3
Barbara Ann Karmanos Cancer Institute1
Cancer Treatment Centers of America1
Case Comprehensive Cancer Center1
City of Hope Medical Center1
Genmab1
Hoag Memorial Hospital Presbyterian1
Jonsson Comprehensive Cancer Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Hairy Cell51
Leukemia, Lymphocytic, Chronic, B-Cell33
Precursor Cell Lymphoblastic Leukemia-Lymphoma33
Burkitt Lymphoma30
Lymphoma, B-Cell, Marginal Zone30
Lymphoma, Non-Hodgkin30
Lymphoma, Follicular29
Lymphoma, Large B-Cell, Diffuse29
Hodgkin Disease28
Lymphoma, Large-Cell, Immunoblastic28

Trials

Showing 1 to 25 of 51. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.